Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 16/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 16/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.36 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.36 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.34 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19804432 | 0.90 | FFAR1 (0.39) | FFAR1FFAR4BACE1BAZ2BBAZ2A | |
| SCHEMBL19801626 | 0.89 | BAZ2B (0.39) | FFAR1FFAR4BACE1BAZ2BBAZ2A | |
| SCHEMBL19804580 | 0.89 | BAZ2B (0.39) | FFAR1FFAR4BACE1BAZ2BBAZ2A | |
| SCHEMBL19796406 | 0.87 | ALOX5 (0.36) | FFAR1FFAR4BAZ2BBAZ2A | |
| SCHEMBL19796924 | 0.86 | THRB (0.43) | — | |
| SCHEMBL19804668 | 0.85 | FFAR1 (0.42) | FFAR1FFAR4 | |
| SCHEMBL19796316 | 0.84 | FFAR4 (0.36) | FFAR1FFAR4 | |
| SCHEMBL19796936 | 0.83 | THRB (0.41) | — | |
| SCHEMBL19804610 | 0.83 | FFAR4 (0.40) | FFAR1FFAR4 | |
| SCHEMBL19804683 | 0.83 | FFAR4 (0.40) | FFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, C1S, AP3D1 | FFAR1 1057/4885FFAR4 1715/4885BACE1 527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.